Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs
Open Access
- 26 November 2007
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 6 (1) , 156
Abstract
The susceptibility of microbes such as Plasmodium falciparum to drugs is measured in vitro as the concentration of the drug achieving 50% of maximum effect (IC50); values from a population are summarized as geometric means. For antimalarial drugs, as well as for antibiotics, assessing changes in microbe susceptibility over time under drug pressure would help inform treatment policy decisions, but no standard statistical method exists as yet. A mixed model was generated on loge-transformed IC50 values and calculated geometric least squares means (GLSM) with 90% confidence intervals (CIs). In order to compare IC50s between years, GLSM ratios (GLSMR) with 90%CIs were calculated and, when both limits of the 90%CIs were below or above 100%, the difference was considered statistically significant. Results were compared to those obtained from ANOVA and a generalized linear model (GLM). GLSMRs were more conservative than ANOVA and resulted in lower levels of statistical significance. The GLSMRs approach allowed for random effect and adjustment for multiple comparisons. GLM was limited in the number of year-to-year comparisons by the need for a single reference year. The three analyses yielded generally consistent results. A robust analytical method can palliate inherent limitations of in vitro sensitivity testing. The random effects GLSMRs with adjustment for multiple comparisons and 90%CIs require only assumptions on the mixed model to be applied. Results are easy to display graphically and to interpret. The GLMSRs should be considered as an option for monitoring changes in drug susceptibility of P. falciparum malaria and other microbes.Keywords
This publication has 17 references indexed in Scilit:
- Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approachMalaria Journal, 2007
- Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory ConcentrationAntimicrobial Agents and Chemotherapy, 2006
- Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off valuesClinical Microbiology and Infection, 2006
- Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance (Southwestern Senegal) during the First 5 Years of Routine Use of Artesunate-AmodiaquineAntimicrobial Agents and Chemotherapy, 2006
- Economic evaluation of a policy change from single‐agent treatment for suspected malaria to artesunate‐amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south‐western SenegalTropical Medicine & International Health, 2005
- Comparison of Oral Artesunate and Dihydroartemisinin Antimalarial Bioavailabilities in Acute Falciparum MalariaAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics of artesunate after single oral administration to ratsBMC Pharmacology, 2001
- Determination of antimicrobial susceptibility test breakpointsClinical Microbiology and Infection, 2000
- In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.Journal of Antimicrobial Chemotherapy, 1998
- Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution techniqueAntimicrobial Agents and Chemotherapy, 1979